TrialAesthetic surgery journal2020

Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial.

Benjamin Ascher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.